The board of Dingdang Health Technology Group Ltd. will convene on 21 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on the payment of an interim dividend, if any. Chairman Yang Wenlong will preside over the meeting, which will take place in Hong Kong. The current board comprises six executive directors and three independent non-executive directors.